Roche shareholders back full slate of proposals, approve record dividend increase
Dr Severin Schwan was re-elected as Chairman of the Board with 97.75% of the votes
Dr Severin Schwan was re-elected as Chairman of the Board with 97.75% of the votes
The Hydrus Microstent stands out as the first and only MIGS device backed by five-year clinical outcomes
Indomo’s ClearPen system combines a proprietary self-injection device and microneedle with a modernized triamcinolone acetonide formulation
Cognita CXR leverages a proprietary vision-language model to analyze full chest X-ray studies and generate comprehensive preliminary findings
The hospitals house over 25 super-speciality centres and Centres of Excellence in Cardiology, Neurology, Oncology, Paediatrics, Orthopaedics, ENT, Obstetrics and Gynaecology, General Surgery, Internal Medicine, Critical Care, and Chronic Disease Management
The study showed a 76% complete response (CR) rate at 12 months, rising to 95% at any time for high-risk NMIBC patients
The initiative provides clearer regulatory guidance and a defined path from research in space to patient access on Earth
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
Germany will be the first launch market
Subscribe To Our Newsletter & Stay Updated